Kennebec Savings Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Buy
9,247
+43
+0.5% +$9.25K 1.87% 11
2026
Q1
$2M Sell
9,204
-5
-0.1% -$1.11K 1.8% 13
2025
Q4
$2.1M Buy
9,209
+122
+1% +$27.8K 1.82% 11
2025
Q3
$2.1M Buy
9,087
+139
+2% +$28.3K 1.92% 9
2025
Q2
$1.66M Sell
8,948
-26
-0.3% -$4.83K 1.63% 12
2025
Q1
$1.88M Buy
8,974
+28
+0.3% +$5.44K 1.99% 9
2024
Q4
$1.58M Sell
8,946
-169
-2% -$31.1K 1.59% 12
2024
Q3
$1.8M Buy
+9,115
New +$1.7M 1.78% 10

Other funds holding ABBV

Kennebec Savings Bank's ABBV Position: Q2 2026 in Review

Kennebec Savings Bank increased its AbbVie (ABBV) stake by 0.47% in Q2 2026, buying an estimated $9.25K and bringing the position to 9,247 shares worth $2.33M. The position accounts for 1.87% of the portfolio, ranked #11.

Kennebec Savings Bank first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 1,625 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kennebec Savings Bank held 9,247 shares of AbbVie worth $2.33M as of Q2 2026.
  • Kennebec Savings Bank bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 1.87% of Kennebec Savings Bank's portfolio in Q2 2026, its #11 holding.
  • Kennebec Savings Bank first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 1,625 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kennebec Savings Bank's 13F filing for Q2 2026, filed 13 Jul 2026.